Milestone Pharmaceuticals, Inc. (MIST)
0.9505
-0.03
(-3.02%)
USD |
NASDAQ |
Sep 14, 16:00
0.9505
0.00 (0.00%)
After-Hours: 16:59
Milestone Pharmaceuticals Market Cap : 118.34M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 122.02M |
| September 10, 2026 | 130.72M |
| September 09, 2026 | 133.21M |
| September 08, 2026 | 140.06M |
| September 04, 2026 | 149.40M |
| September 03, 2026 | 150.64M |
| September 02, 2026 | 146.91M |
| September 01, 2026 | 141.93M |
| August 31, 2026 | 144.42M |
| August 28, 2026 | 144.42M |
| August 27, 2026 | 148.15M |
| August 26, 2026 | 146.91M |
| August 25, 2026 | 144.42M |
| August 24, 2026 | 129.48M |
| August 21, 2026 | 131.35M |
| August 20, 2026 | 128.23M |
| August 19, 2026 | 134.46M |
| August 18, 2026 | 133.21M |
| August 17, 2026 | 136.95M |
| August 14, 2026 | 136.95M |
| August 13, 2026 | 133.21M |
| August 12, 2026 | 140.06M |
| August 11, 2026 | 158.11M |
| August 10, 2026 | 156.87M |
| August 07, 2026 | 151.89M |
| Date | Value |
|---|---|
| August 06, 2026 | 139.00M |
| August 05, 2026 | 134.87M |
| August 04, 2026 | 137.82M |
| August 03, 2026 | 131.93M |
| July 31, 2026 | 130.75M |
| July 30, 2026 | 135.46M |
| July 29, 2026 | 122.51M |
| July 28, 2026 | 126.04M |
| July 27, 2026 | 133.11M |
| July 24, 2026 | 136.64M |
| July 23, 2026 | 141.35M |
| July 22, 2026 | 140.18M |
| July 21, 2026 | 144.89M |
| July 20, 2026 | 139.00M |
| July 17, 2026 | 139.59M |
| July 16, 2026 | 146.07M |
| July 15, 2026 | 149.60M |
| July 14, 2026 | 153.13M |
| July 13, 2026 | 150.78M |
| July 10, 2026 | 150.78M |
| July 09, 2026 | 154.31M |
| July 08, 2026 | 143.71M |
| July 07, 2026 | 151.95M |
| July 06, 2026 | 155.49M |
| July 02, 2026 | 155.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 6.968M |
| NervGen Pharma Corp. | 233.04M |
| Clearmind Medicine, Inc. | 0.9376M |
| Lexaria Bioscience Corp. | 5.800M |
| Target Group, Inc. (Canada) | 0.6787M |
Market Cap Related Metrics
| PS Ratio | 47.84 |
| Price to Book Value | 6.496 |
| Price | 0.9505 |
| Earnings Yield | -72.99% |